20 Mar 20
News
20 Mar 20

Biocomposites Status on Novel Coronavirus (COVID-19)

The recent events and rise of the COVID-19 virus on a global scale have brought challenges to us in ways that were unimaginable at the beginning of the year. We have been following the guidance published by the governments in the countries that we operate in to keep our employees safe, whilst ensuring that we continue to manufacture our lifesaving products.

Our warehouses are stocked – including our newly opened facilities in the US and UK – and we have every confidence that we can continue to meet the needs of our distributors, hospital partners and their surgeons.

We are executing new site access guidelines to restrict visitors to our facilities and conducting a staff capability review across all functions to ensure we have cover in business-critical processes.

As always, we remain focused on supporting the wellbeing and safety of our staff and delivering our excellent products to patients and hospitals worldwide.

Thank you and best wishes through this period.

About Biocomposites

Biocomposites is an international medical device company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue. Based in Keele, UK, it has global operations across Europe, USA, Canada, China and India. Biocomposites is a world leader in the development of innovative calcium compounds for surgical use. Its products target a broad spectrum of infection risks across a variety of specialities, including musculoskeletal infection, orthopaedics, trauma, spine, foot and ankle and podiatry. Biocomposites products are now used in over 100,000 procedures per annum and sold in more than 40 countries around the world. Please visit biocomposites.com to learn more.

Other news

Listed below is a list of the 4 most recent news updates made by Biocomposties


Visit our News & Events page

Evidence

Interested in other types of our content? See a list of some of our most recent evidence below.

Explore evidence